Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary W. Pace currently holds 1,345,676 shares of Cardiff Oncology, Inc. (CRDF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary W. Pace has been a net seller of CRDF stock. They have purchased $2.8M and sold $32.7M worth of shares.
Gary W. Pace's most recent insider trade was on Jul 30, 2025, when they purchased 15,000 shares at $2.45 per share.
Gary W. Pace serves as Executive at Cardiff Oncology, Inc. (CRDF). They have executed 105 insider transactions totaling $35.5M over their tenure at the company.
Gary W. Pace holds the position of Executive at Cardiff Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gary W. Pace has shown a selling trading pattern, with $2.8M in total purchases and $32.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gary W. Pace was on May 8, 2018, when they sold $2.8M worth of RMD shares. This transaction involved 28,403 shares at $97.37 per share.
Gary W. Pace currently owns 1,345,676 shares of Cardiff Oncology, Inc. (CRDF), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary W. Pace's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary W. Pace has 105 Form 4 filings on record as an insider at Cardiff Oncology, Inc..
Set alerts for Gary W. Pace and 40,000+ other insiders.